These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9839329)

  • 21. Scintimammography: the new role of technetium-99m Sestamibi imaging for the diagnosis of breast carcinoma.
    Khalkhali I; Iraniha S; Diggles LE; Cutrone JA; Mishkin FS
    Q J Nucl Med; 1997 Sep; 41(3):231-8. PubMed ID: 9274131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer.
    Bagni B; Franceschetto A; Casolo A; De Santis M; Bagni I; Pansini F; Di Leo C
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1383-8. PubMed ID: 12910383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions.
    Tiling R; Sommer H; Pechmann M; Moser R; Kress K; Pfluger T; Tatsch K; Hahn K
    J Nucl Med; 1997 Jan; 38(1):58-62. PubMed ID: 8998151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [++Scintimammography: a new imaging technique for diagnosis and follow-up of breast cancer].
    Hermans J; Bodart F; François D; Merlo P; Fauconnier JP; Schmitz A; Gérard R; de Ruyver D; Eeckhoudt L
    Bull Cancer; 2000 Apr; 87(4):334-40. PubMed ID: 10827352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of early and double phase 99Tcm-sestamibi scintimammography in the diagnosis of breast cancer.
    Paz A; Melloul M; Cytron S; Koren R; Ohana G; Michalevich D; Gal R; Wolloch Y
    Nucl Med Commun; 2000 Apr; 21(4):341-8. PubMed ID: 10845222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
    Delpassand ES; Jackson EF
    Radiology; 1997 Oct; 205(1):283-4; author reply 285-6. PubMed ID: 9315002
    [No Abstract]   [Full Text] [Related]  

  • 28. Tc-99m sestamibi scintimammography: where is it now?
    Schillaci O; Scopinaro F
    Cancer Biother Radiopharm; 1999 Dec; 14(6):417-22. PubMed ID: 10850328
    [No Abstract]   [Full Text] [Related]  

  • 29. Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging.
    Tiling R; Tatsch K; Sommer H; Meyer G; Pechmann M; Gebauer K; Münzing W; Linke R; Khalkhali I; Hahn K
    J Nucl Med; 1998 May; 39(5):849-56. PubMed ID: 9591588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of 99mTC-Sestamibi in the diagnosis of breast cancer. Report on 100 cases].
    Fliquete Peris MV; Giménez Climent J; Vázquez Forner C; Más Arcas C; Vázquez Albaladejo C
    Rev Esp Med Nucl; 1999 Dec; 18(6):436-41. PubMed ID: 10611570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
    Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
    J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scintimammography with 99mTc-sestamibi as a complementary diagnostic technique.
    Torkzad MR
    Acta Radiol; 2001 May; 42(3):345. PubMed ID: 11419397
    [No Abstract]   [Full Text] [Related]  

  • 34. Scintimammography (SMM) in breast cancer patients.
    Mangkharak J
    J Med Assoc Thai; 1999 Mar; 82(3):242-9. PubMed ID: 10410478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of external radioactive markers in scintimammography.
    Klein M; Weininger J; Moshe S; Peretz T; Chisin R
    Clin Nucl Med; 2001 Jan; 26(1):10-3. PubMed ID: 11139045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
    Servais F; Blocklet DC; Seret AE; Lenaers A; Schoutens AC
    Radiology; 1997 Oct; 205(1):283; author reply 285-6. PubMed ID: 9315001
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology.
    Ortapamuk H; Ozmen MM; Ibis S; Naldöken S; Aksoy F
    Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
    Taillefer R; Robidoux A; Turpin S; Lambert R; Cantin J; Léveillé J
    J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tc-99m sestamibi exam finds niche in breast Dx.
    Chen EM; Khalkhali I; Cutrone JA; Diggles LE; Mishkin F
    Diagn Imaging (San Franc); 1997 Aug; 19(8):61-5. PubMed ID: 10169379
    [No Abstract]   [Full Text] [Related]  

  • 40. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
    Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
    Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.